for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

LifeAssays AB (publ)

LIFEb.NGM

Latest Trade

0.59SEK

Change

0.05(+9.26%)

Volume

1,114,513

Today's Range

0.52

 - 

0.59

52 Week Range

0.35

 - 

2.59

As of on the Nordic Growth Market ∙ Minimum 15 minute delay

Pricing

Previous Close
0.54
Open
0.54
Volume
1,114,513
3M AVG Volume
7.67
Today's High
0.59
Today's Low
0.52
52 Week High
2.59
52 Week Low
0.35
Shares Out (MIL)
65.17
Market Cap (MIL)
32.71
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

LifeAssays General Meeting Decides Company To Continue Operations

LifeAssays Board To Propose To Continue Operations

LifeAssays Gets Patent Approved In Europe

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About LifeAssays AB (publ)

LifeAssays publ AB is a Sweden-based diagnostic company. It is engaged in the provision of in-house diagnostic testing for community health centers and physicians, as well as for home use and veterinary applications. The Company develops and markets point-of-care testing (POCT) instruments and technology for the diagnosis of diabetes, renal dysfunction and cardiovascular diseases. The Company’s business portfolio comprises such products, as LifeAssays Canine CRP Test Kit, which monitors inflammation in dogs for early disease intervention; LifeAssays CRP Test Kit, which is a reagent kit for high-sensitive C-Reactive Protein (hsCRP) and normal range C-Reactive Protein (CRP) in whole blood; LifeAssays Reader, which utilizes a disposable algorithm chip containing all reagent identification data, as well as, a self-executable algorithm; and LifeAssays Vet Reader, which offers veterinary practitioners all the functions provided with the LifeAssays Reader.

Industry

Medical Equipment & Supplies

Contact Info

Solvegatan 43 A

+46.46.2865400

http://www.lifeassays.com

Executive Leadership

Anders Norling

Chairman of the Board

Anders Ingvarsson

Chief Executive Officer

Margareta Kriz

Chief Financial Officer

Tom Liber

Director of Sales

Anders Drews

Production and F&U Manager

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
6.15
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-450.08
Return on Equity (TTM)
-170.24

Latest News

Latest News

BRIEF-LifeAssays Q1 Loss After Tax Widens To SEK 5.4 Million

* JAN-MARCH NET REVENUE SEK 1.4 MILLION VERSUS SEK 1.6 MILLION YEAR AGO

BRIEF-LifeAssays Proposes Rights Issue Of About SEK 22.2 Million

* ISSUE IS GUARANTEED TO 100 PERCENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-LifeAssays Says Shareholders Decide To Reject Proposal For Liquidation

* SAYS SHAREHOLDERS DECIDE TO REJECT PROPOSAL FOR LIQUIDATION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-LifeAssays Starts Cooperation With Clientrax In US

* LIFEASSAYS ® AB AND CLIENTRAX START COOPERATION IN THE UNITED STATES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Lifeassays AB (Publ) Oct-Dec Net Sales Up at Sek 2 Million

* OCT-DEC NET SALES SEK 2 MILLION VERSUS SEK 1.8 MILLION YEAR AGO

BRIEF-LifeAssays Raises SEK 8.9 Mln In Rights Issue

* RIGHTS ISSUE SUBSCRIBED TO 42.4 PERCENT WITH PROCEEDS AT SEK 8.9 MILLION BEFORE ISSUE COSTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-LifeAssays ‍Gets Order From US

* TOTAL ORDER VALUE OF SEK 255,000 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Lifeassays Q3 operating loss widens to SEK 4.8 mln

* Q3 NET SALES SEK 1.3 MILLION VERSUS SEK 1.6 MILLION YEAR AGO

BRIEF-Lifeassays installs five VetReader systems in Northern Germany

* INSTALLS FIVE VETREADER SYSTEMS IN NORTHERN GERMANY, ORDER VALUE ABOUT SEK 45,000 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-LifeAssays: directed issue to StGrand Asset management discontinued

* DIRECTED ISSUE TO STGRAND ASSET MANAGEMENT DISCONTINUED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-LifeAssays Q2 operating loss widens to SEK 5.3 million

* Q2 NET SALES SEK 1.8 MILLION VERSUS SEK 2.2 MILLION YEAR AGO

BRIEF-LifeAssays: distributor in China places order for 50 instruments

* DELIVERY TO TAKE PLACE IN Q2 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-LifeAssays resolves on directed share issue

* Decided to conduct a issue of 165,634,323 new B shares, equivalent to about 9.99 percent of outstanding shares

BRIEF-Lifeassays Q4 operating loss widens to SEK 5.0 million

* Q4 total revenue 1.9 million crowns versus 1.2 million crowns year ago

BRIEF-LifeAssays Q3 operating loss widens to SEK 4.2 million

* Q3 net sales 1.6 million Swedish crowns ($175,000) versus 0.9 million crowns year ago

BRIEF-LifeAssays announces new partner for Lithuania, gets order of EUR 3,450

* Signs Letter of Intent with Interlux for marketing and sales of LifeAssays products in Lithuania

BRIEF-Lifeassays: Italian distributor places order for 10 instruments

LifeAssays AB (publ) : * Italian distributor places order for 10 instruments Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up